INTRA CELLULAR THERAPIES INC

Profile

Company Names

INTRA CELLULAR THERAPIES INC

Addresses

AUDUBON BIOMEDICAL SCIENCE, + TECHNOLOGY PARK, 3960 BROADWAY, NEW YORK, NY 10032

Phone Numbers

212-923-3344

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$80,867,306.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-08-29 
$60,000,000.00 
$60,000,000.00 
$0.00 
Equity 
3
2013-04-19 
$241,633.00 
$241,633.00 
$0.00 
Equity 
2
2012-10-25 
$15,289,893.00 
$15,400,000.00 
$110,107.00 
Debt 
1
2010-02-26 
$5,335,780.00 
$8,000,000.00 
$2,664,220.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
ALAFI 
DIRECTOR
ALLEN 
 
FIENBERG 
EXECUTIVE OFFICER
LAWRENCE 
 
HINELINE 
EXECUTIVE OFFICER
LAWRENCE 
J. 
HINELINE 
EXECUTIVE OFFICER
DAVID 
 
KIPNIS 
DIRECTOR
SHARON 
 
MATES 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
RAWLINS 
DIRECTOR
SIR MICHAEL 
 
RAWLINS 
DIRECTOR
KIMBERLY 
 
VANOVER 
EXECUTIVE OFFICER
LAWRENCE 
 
WENNOGLE 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-19 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK SWANN LLC
NONE
NONE
NATIONAL SECURITIES CORPORATION
NONE
NONE
LIVINGSTON SECURITIES, LLC